Agilent 29. Mai 2026 Agilent Technologies (A) Margin Gains Reinforce Bullish Recurring Revenue Narrative After Q2 2026 Results - simplywall.st
FierceBiotech 29. Mai 2026 ASCO: BMS’ CELMoD drug doubles PFS in ‘incredibly exciting’ ph. 3 myeloma study
FierceBiotech 29. Mai 2026 ASCO: Lilly debuts ‘strong’ bladder cancer data for potential Padcev challenger
FierceBiotech 29. Mai 2026 Gilead scraps lead arthritis drug from $405M MiroBio buyout in latest blow to BTLA agonist field
Endpoints News 29. Mai 2026 David Chang to hand over the reins at Allogene; Ex-Esperion CEO gets started at Phlow
Endpoints News 29. Mai 2026 Pfizer strikes Innovent deal worth up to $10.5B for a dozen cancer programs
Illumina 29. Mai 2026 Illumina and SPT Labtech launch fireflyGO for automated oncology research - Yahoo Tech
Edwards Lifesciences 29. Mai 2026 Boston Scientific’s $1.5B bet signals heart valve market battle - Modern Healthcare
FierceBiotech 29. Mai 2026 Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation